These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 11893875

  • 1. Bupropion as add-on strategy in difficult-to-treat bipolar depressive patients.
    Erfurth A, Michael N, Stadtland C, Arolt V.
    Neuropsychobiology; 2002; 45 Suppl 1():33-6. PubMed ID: 11893875
    [Abstract] [Full Text] [Related]

  • 2. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers.
    Leverich GS, Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck PE, Kupka RW, Denicoff KD, Nolen WA, Grunze H, Martinez MI, Post RM.
    Am J Psychiatry; 2006 Feb; 163(2):232-9. PubMed ID: 16449476
    [Abstract] [Full Text] [Related]

  • 3. Bupropion as an add-on therapy in depressed bipolar disorder type I patients with comorbid cocaine dependence.
    Sepede G, Di lorio G, Lupi M, Sarchione F, Acciavatti T, Fiori F, Santacroce R, Martinotti G, Gambi F, Di Giannantonio M.
    Clin Neuropharmacol; 2014 Feb; 37(1):17-21. PubMed ID: 24434527
    [Abstract] [Full Text] [Related]

  • 4. Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers.
    Post RM, Altshuler LL, Frye MA, Suppes T, Rush AJ, Keck PE, McElroy SL, Denicoff KD, Leverich GS, Kupka R, Nolen WA.
    Bipolar Disord; 2001 Oct; 3(5):259-65. PubMed ID: 11912569
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness of adjunctive antidepressant treatment for bipolar depression.
    Sachs GS, Nierenberg AA, Calabrese JR, Marangell LB, Wisniewski SR, Gyulai L, Friedman ES, Bowden CL, Fossey MD, Ostacher MJ, Ketter TA, Patel J, Hauser P, Rapport D, Martinez JM, Allen MH, Miklowitz DJ, Otto MW, Dennehy EB, Thase ME.
    N Engl J Med; 2007 Apr 26; 356(17):1711-22. PubMed ID: 17392295
    [Abstract] [Full Text] [Related]

  • 6. Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline.
    Post RM, Altshuler LL, Leverich GS, Frye MA, Nolen WA, Kupka RW, Suppes T, McElroy S, Keck PE, Denicoff KD, Grunze H, Walden J, Kitchen CM, Mintz J.
    Br J Psychiatry; 2006 Aug 26; 189():124-31. PubMed ID: 16880481
    [Abstract] [Full Text] [Related]

  • 7. The Expert Consensus Guidelines for treating depression in bipolar disorder.
    Frances AJ, Kahn DA, Carpenter D, Docherty JP, Donovan SL.
    J Clin Psychiatry; 1998 Aug 26; 59 Suppl 4():73-9. PubMed ID: 9554324
    [Abstract] [Full Text] [Related]

  • 8. A double-blind trial of bupropion versus desipramine for bipolar depression.
    Sachs GS, Lafer B, Stoll AL, Banov M, Thibault AB, Tohen M, Rosenbaum JF.
    J Clin Psychiatry; 1994 Sep 26; 55(9):391-3. PubMed ID: 7929019
    [Abstract] [Full Text] [Related]

  • 9. An open trial of bupropion for the treatment of adults with attention-deficit/hyperactivity disorder and bipolar disorder.
    Wilens TE, Prince JB, Spencer T, Van Patten SL, Doyle R, Girard K, Hammerness P, Goldman S, Brown S, Biederman J.
    Biol Psychiatry; 2003 Jul 01; 54(1):9-16. PubMed ID: 12842303
    [Abstract] [Full Text] [Related]

  • 10. [Manic Shift Due to the Use of Bupropion in Bipolar Depression:Two Case Reports].
    Kahyacı Kılıç E, Görgülü Y, Köse Çınar R, Sönmez MB.
    Turk Psikiyatri Derg; 2019 Jul 01; 30(2):145-148. PubMed ID: 31487381
    [Abstract] [Full Text] [Related]

  • 11. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM, Anderson I, Arango C, Bowden CL, Henry C, Mitchell PB, Nolen WA, Vieta E, Wittchen HU.
    Eur Neuropsychopharmacol; 2008 Jul 01; 18(7):535-49. PubMed ID: 18501566
    [Abstract] [Full Text] [Related]

  • 12. A double-blind study comparing idazoxan and bupropion in bipolar depressed patients.
    Grossman F, Potter WZ, Brown EA, Maislin G.
    J Affect Disord; 1999 Dec 01; 56(2-3):237-43. PubMed ID: 10701483
    [Abstract] [Full Text] [Related]

  • 13. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F, Berk M, Frye MA, Wang W, Barraco A, Tohen M.
    J Clin Psychiatry; 2009 Oct 01; 70(10):1424-31. PubMed ID: 19906346
    [Abstract] [Full Text] [Related]

  • 14. Venlafaxine and bupropion combination therapy in a case of treatment-resistant depression.
    Fatemi SH, Emamian ES, Kist DA.
    Ann Pharmacother; 1999 Jun 01; 33(6):701-3. PubMed ID: 10410184
    [Abstract] [Full Text] [Related]

  • 15. Mania with bupropion: a dose-related phenomenon?
    Goren JL, Levin GM.
    Ann Pharmacother; 2000 May 01; 34(5):619-21. PubMed ID: 10852090
    [Abstract] [Full Text] [Related]

  • 16. [Are there substantial reasons for contraindicating antidepressants in bipolar disorder? Part II: facts or artefacts?].
    Hausmann A, Hörtnagl C, Walpoth M, Fuchs M, Conca A.
    Neuropsychiatr; 2007 May 01; 21(2):131-58. PubMed ID: 17640499
    [Abstract] [Full Text] [Related]

  • 17. Low dosage lithium augmentation in venlafaxine resistant depression: an open-label study.
    Alevizos B, Alevizos E, Leonardou A, Zervas I.
    Psychiatriki; 2012 May 01; 23(2):143-8. PubMed ID: 22796912
    [Abstract] [Full Text] [Related]

  • 18. Rational polypharmacy in the bipolar affective disorders.
    Post RM, Ketter TA, Pazzaglia PJ, Denicoff K, George MS, Callahan A, Leverich G, Frye M.
    Epilepsy Res Suppl; 1996 May 01; 11():153-80. PubMed ID: 9294735
    [Abstract] [Full Text] [Related]

  • 19. Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants.
    Altshuler LL, Suppes T, Black DO, Nolen WA, Leverich G, Keck PE, Frye MA, Kupka R, McElroy SL, Grunze H, Kitchen CM, Post R.
    Am J Psychiatry; 2006 Feb 01; 163(2):313-5. PubMed ID: 16449487
    [Abstract] [Full Text] [Related]

  • 20. Extended-release bupropion: an antidepressant with a broad spectrum of therapeutic activity?
    Clayton AH.
    Expert Opin Pharmacother; 2007 Mar 01; 8(4):457-66. PubMed ID: 17309340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.